330 related articles for article (PubMed ID: 9578182)
1. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man.
Kupferschmidt HH; Fattinger KE; Ha HR; Follath F; Krähenbühl S
Br J Clin Pharmacol; 1998 Apr; 45(4):355-9. PubMed ID: 9578182
[TBL] [Abstract][Full Text] [Related]
2. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
Eagling VA; Profit L; Back DJ
Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
[TBL] [Abstract][Full Text] [Related]
4. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
5. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Oct; 68(4):384-90. PubMed ID: 11061578
[TBL] [Abstract][Full Text] [Related]
6. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
Malhotra S; Bailey DG; Paine MF; Watkins PB
Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
[TBL] [Abstract][Full Text] [Related]
7. Effects of grapefruit juice on the pharmacokinetics of sildenafil.
Jetter A; Kinzig-Schippers M; Walchner-Bonjean M; Hering U; Bulitta J; Schreiner P; Sörgel F; Fuhr U
Clin Pharmacol Ther; 2002 Jan; 71(1):21-9. PubMed ID: 11823754
[TBL] [Abstract][Full Text] [Related]
8. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice.
Tassaneeyakul W; Vannaprasaht S; Yamazoe Y
Br J Clin Pharmacol; 2000 Feb; 49(2):139-44. PubMed ID: 10671908
[TBL] [Abstract][Full Text] [Related]
9. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam.
Yasui N; Kondo T; Furukori H; Kaneko S; Ohkubo T; Uno T; Osanai T; Sugawara K; Otani K
Psychopharmacology (Berl); 2000 Jun; 150(2):185-90. PubMed ID: 10907671
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo.
Dresser GK; Wacher V; Wong S; Wong HT; Bailey DG
Clin Pharmacol Ther; 2002 Sep; 72(3):247-55. PubMed ID: 12235445
[TBL] [Abstract][Full Text] [Related]
11. Red wine-cisapride interaction: comparison with grapefruit juice.
Offman EM; Freeman DJ; Dresser GK; Munoz C; Bend JR; Bailey DG
Clin Pharmacol Ther; 2001 Jul; 70(1):17-23. PubMed ID: 11452240
[TBL] [Abstract][Full Text] [Related]
12. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Bailey DG; Dresser GK; Bend JR
Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
[TBL] [Abstract][Full Text] [Related]
13. Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans.
Bailey DG; Kreeft JH; Munoz C; Freeman DJ; Bend JR
Clin Pharmacol Ther; 1998 Sep; 64(3):248-56. PubMed ID: 9757148
[TBL] [Abstract][Full Text] [Related]
14. The effects of grapefruit juice on the pharmacokinetics of erythromycin.
Kanazawa S; Ohkubo T; Sugawara K
Eur J Clin Pharmacol; 2001; 56(11):799-803. PubMed ID: 11294369
[TBL] [Abstract][Full Text] [Related]
15. Saquinavir with grapefruit juice.
Posit Aware; 1996; 7(1):5. PubMed ID: 11363122
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.
Fuhr U
Drug Saf; 1998 Apr; 18(4):251-72. PubMed ID: 9565737
[TBL] [Abstract][Full Text] [Related]
17. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid.
Kantola T; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1998 Apr; 63(4):397-402. PubMed ID: 9585793
[TBL] [Abstract][Full Text] [Related]
18. Grapefruit juice-drug interactions.
Bailey DG; Malcolm J; Arnold O; Spence JD
Br J Clin Pharmacol; 1998 Aug; 46(2):101-10. PubMed ID: 9723817
[TBL] [Abstract][Full Text] [Related]
19. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.
Veronese ML; Gillen LP; Burke JP; Dorval EP; Hauck WW; Pequignot E; Waldman SA; Greenberg HE
J Clin Pharmacol; 2003 Aug; 43(8):831-9. PubMed ID: 12953340
[TBL] [Abstract][Full Text] [Related]
20. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
